How Food Processing Impacts Hyperkalemia and Hyperphosphatemia Management in Chronic Kidney Disease

被引:6
|
作者
Picard, Kelly [1 ,2 ]
Mager, Diana [1 ]
Richard, Caroline [1 ]
机构
[1] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada
[2] Alberta Hlth Serv, Nutr Serv, Edmonton, AB, Canada
关键词
CONSUMPTION; PHOSPHORUS; ADDITIVES; DIET; PREVALENCE; POTASSIUM; PRODUCTS; POULTRY; CANADA; SODIUM;
D O I
10.3148/cjdpr-2020-003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Food processing has a unique impact on patients living with chronic kidney disease who may need to restrict dietary sodium, potassium, and phosphorus intake. Canada is the second largest consumer of processed food in the world. Highly processed foods tend to be more nutrient dense, contain less fibre, and are higher in sodium than unprocessed foods. To reduce the amount of sodium in processed food, Health Canada has encouraged food producers to reduce the sodium in their food. Potassium additives have been identified as an attractive alternative to sodium and their use in food processing is expected to increase. Phosphorus additives have been reported to be present in about 44% of processed foods. Given the changes in the nutrient profiles of processed foods, dietary advice on ways to reduce sodium, potassium, and phosphorus intake may be best achieved by recommending minimally processed food and encouraging unprocessed foods more often.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [21] A SYSTEMATIC REVIEW OF ONLINE MATERIALS ON DIETARY MANAGEMENT OF HYPERPHOSPHATEMIA IN PEOPLE WITH CHRONIC KIDNEY DISEASE
    Begum, Most Murshida
    Biruete, Annabel
    Kistler, Brandon
    St-Jules, David
    Meade, Anthony
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S47 - S47
  • [22] Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients
    Ramos, Ana M.
    Albalate, Marta
    Vazquez, Silvia
    Caramelo, Carlos
    Egido, Jesus
    Ortiz, Alberto
    KIDNEY INTERNATIONAL, 2008, 74 : S88 - S93
  • [23] Advances in treatment of hyperkalemia in chronic kidney disease
    Sarafidis, Pantelis A.
    Georgianos, Panagiotis I.
    Bakris, George L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (14) : 2205 - 2215
  • [24] A Systematic Review of Online Resources for the Dietary Management of Hyperphosphatemia in People With Chronic Kidney Disease
    Begum, Most Murshida
    Biruete, Annabel
    Kistler, Brandon
    Meade, Anthony
    Westhoff, John
    St-Jules, David E.
    JOURNAL OF RENAL NUTRITION, 2024, 34 (05) : 410 - 417
  • [25] Strategies aiming to control hyperphosphatemia in chronic kidney disease
    Torres, Pablo Antonio Urena
    NEPHROLOGIE & THERAPEUTIQUE, 2017, 13 : S95 - S101
  • [26] A new approach to the evaluation of hyperphosphatemia in chronic kidney disease
    Savica, V.
    Calo, L. A.
    Granata, A.
    Caldarera, R.
    Cavaleri, A.
    Santoro, D.
    Monardo, P.
    Savica, R.
    Muraca, U.
    Bellinghieri, G.
    CLINICAL NEPHROLOGY, 2007, 68 (04) : 216 - 221
  • [27] Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis
    Nolan, CR
    Qunibi, WY
    KIDNEY INTERNATIONAL, 2005, 67 : S13 - S20
  • [28] The control of hyperphosphatemia in chronic kidney disease: Which phosphate binder?
    Ketteler, Markus
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (02): : 95 - 100
  • [29] The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
    Einhorn, Lisa M.
    Zhan, Min
    Hsu, Van Doren
    Walker, Lori D.
    Moen, Maureen F.
    Seliger, Stephen L.
    Weir, Matthew R.
    Fink, Jeffrey C.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (12) : 1156 - 1162
  • [30] Hyperphosphatemia: a novel risk factor for mortality in chronic kidney disease
    Cozzolino, Mario
    Ciceri, Paola
    Galassi, Andrea
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (03)